Coldstream Capital Management Inc Fulcrum Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 105 shares of FULC stock, worth $599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105Holding current value
$599% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FULC
# of Institutions
126Shares Held
51.1MCall Options Held
715KPut Options Held
11.8K-
Ra Capital Management, L.P. Boston, MA10.2MShares$58.4 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$30 Million3.64% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$27.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$27.3 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$19.1 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $297M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...